Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CryoLife/Medafor

This article was originally published in The Gray Sheet

Executive Summary

CryoLife boosts its equity stake in privately held surgical hemostat maker Medafor to 11% through the purchase of 740,000 shares at $2 each, announced Feb. 2. Surgical adhesive maker CryoLife, which remains Medafor's largest shareholder, is seeking a negotiated acquisition of the rest of Medafor (1"The Gray Sheet" Jan. 18, 2010). While Medafor's board is weighing its options, CryoLife says it may seek a special shareholders meeting to replace the board
Advertisement
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

MT028462

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel